Dexcom (Nasdaq:DXCM) today announced a significant investment and health monitoring partnership involving its CGM technology. Our sister site, Drug Delivery Business News, reports today that the San Diego-based continuous glucose monitor maker invested $75 million in Oura, maker of the Oura Ring, a smart ring that delivers vital sign, sleep, stress, heart health and activity […]
Dexcom
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Dexcom’s third-quarter earnings report included news of a significant submission to the FDA for the company’s latest-generation technology. Our sister site, Drug Delivery Business News, reported that San Diego-based Dexcom submitted a 15-day version of its G7 continuous glucose monitor (CGM) to the FDA. The technology previously had a wear time of 10 days. This would […]
The top 10 connected health stories of the year so far
The shift to more connected health isn’t showing signs of slowing down, and medtech continues to play a significant role. Especially in the United States, there is still a need for reforms in how healthcare is delivered and paid for to enable more remote delivery of healthcare monitoring and therapies. Nevertheless, the medtech behind connected […]
Dexcom launches Stelo over-the-counter CGM
Dexcom today announced a significant product launch as another continuous glucose monitor (CGM) is hitting the market. Our sister site, Drug Delivery Business News, reported today that Dexcom launched its Stelo over-the-counter (OTC) CGM biosensor. The San Diego-based company designed Stelo, a small, wearable sensor, specifically for people with type 2 diabetes who do not use […]
The 9 largest diabetes tech companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Tandem Diabetes Care integrates t:slim X2 with Dexcom CGMs in Canada
Tandem Diabetes Care (Nasdaq:TNDM) continues to expand its diabetes treatment partnership with Dexcom (Nasdaq:DXCM). Our sibling site, Drug Delivery Business News, reported today that Tandem has launched its updated t:slim X2 insulin pump software with Dexcom CGMs in Canada. San Diego–based Tandem now offers the t:slim X2 pump software with the Dexcom G6 and G7 continuous glucose […]
Dexcom stock falls on Q2 results that came up shy of ‘high standards’
Dexcom — a major provider of continuous glucose monitors — is seeing its stock price plummet on lowered sales guidance and mixed Q2 results. Our sibling site, Drug Delivery Business News, reports that shares of DXCM were more than 40% to $63.96 apiece in morning trading today. MassDevice‘s MedTech 100 Index was down slightly. The […]
Report: Dexcom cuts California jobs in manufacturing, R&D shift
Dexcom (Nasdaq:DXCM) is reportedly relocating manufacturing operations amid a shift that eliminates more than 500 positions in San Diego. The San Diego Union-Tribune reported that the company plans to keep its headquarters in San Diego. However, its decision to move manufacturing to Arizona signals that Dexcom outgrew its facilities in San Diego. The move takes […]
The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions
The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech. Topics covered included expanding technologies to the type 2 diabetes population (90% of people with diabetes), GLP-1 drugs, automation, broadening user bases and more. The usual big-hitters stepped up to the plate […]
Dexcom CEO explains plans for Stelo CGM, G7 and beyond
Dexcom (Nasdaq:DXCM) CEO Kevin Sayer says the prospect of an over-the-counter CGM made him and other company leaders uneasy. When the company first began planning a glucose monitor for the type 2 diabetes population not using insulin, there were questions about reimbursement, the impact of GLP-1 drugs and other causes for concern. “It made us […]
Insulet fully launches Omnipod 5 with Dexcom G7 in the U.S. along with iPhone app
Insulet (Nasdaq:PODD) announced today that it began a full U.S. launch of Omnipod 5 with the Dexcom G7 continuous glucose monitor (CGM). The company also announced a series of launches and updates, including a limited release of the Omnipod 5 App for iPhone. Insulet also made Omnipod 5 available in France and launched the system […]
